Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 1, 1992Molecular EndocrinologyOpen Access

An enhancer element responsive to ras and fms signaling pathways is composed of two distinct nuclear factor binding sites.

View Full Paper
Ask AI
Bookmark
Share

Authors

MRMarpadga A. ReddyCity of HopeSLSteve J. LangerMCMichael S. ColmanNational Institute of Environmental Health Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Reddy et al. (1992) studied this question.

synapsesocial.com/papers/6a95dc822259ab2500e6cebchttps://doi.org/10.1210/mend.6.7.1324418
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.1990 · 187 citations
  2. 2Inhibition of v-src-induced transformation by a GTPase-activating protein.1991 · 91 citations
  3. 3Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP)1990 · 303 citations